Great Lakes Advisors, LLC Corcept Therapeutics Inc Transaction History

Great Lakes Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$24.82 - $32.88 $138,570 - $183,569	-5,583 Reduced 1.63%	335,895 $10.9 Million
Q3 2023 Nov 07, 2023	SELL	$21.97 - $33.8 $109,696 - $168,763	-4,993 Reduced 1.44%	341,478 $9.31 Million
Q2 2023 Aug 10, 2023	SELL	$21.44 - $25.15 $50,148 - $58,825	-2,339 Reduced 0.67%	346,471 $7.71 Million
Q1 2023 May 10, 2023	SELL	$19.2 - $24.47 $365,894 - $466,324	-19,057 Reduced 5.18%	348,810 $7.56 Million
Q4 2022 Feb 09, 2023	SELL	$19.95 - $29.96 $179,310 - $269,280	-8,988 Reduced 2.39%	367,867 $7.47 Million
Q3 2022 Nov 09, 2022	SELL	$24.7 - $29.12 $182,187 - $214,789	-7,376 Reduced 1.92%	376,855 $9.66 Million
Q2 2022 Aug 09, 2022	SELL	$17.33 - $25.3 $99,959 - $145,930	-5,768 Reduced 1.48%	384,231 $9.14 Million
Q1 2022 May 06, 2022	BUY	$16.53 - $25.21 $6.45 Million - $9.83 Million	389,999 New	389,999 $8.78 Million

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.